Abstract:Cerebral hypoperfusion‐induced increased activity of the SPAK‐NKCC1 pathway contributes to reactive astrogliosis and subsequent demyelination and cognitive impairment in a mouse model of vascular dementia. SPAk inhibitor ZT‐1 improved cognitive impairment by preventing reactive astrogliosis and demyelination. Therefore, SPAK‐NKCC1 can be a potential therapeutic target for treating vascular dementia. Background Astrogliosis and white matter lesions (WML) are key characteristics of vascular contributions to cognitive impairment and dementia (VCID). However, the molecular mechanisms underlying VCID remain poorly understood. Stimulation of Na‐K‐Cl cotransport 1 (NKCC1) and its upstream kinases WNK (with no lysine) and SPAK (the STE20/SPS1‐related proline/alanine‐rich kinase) play a role in astrocytic intracellular Na+ overload, hypertrophy, and swelling. Therefore, in this study, we assessed the effect of SPAK inhibitor ZT‐1a on pathogenesis and cognitive function in a mouse model of VCID induced by bilateral carotid artery stenosis (BCAS). Methods Following sham or BCAS surgery, mice were randomly assigned to receive either vehicle (DMSO) or SPAK inhibitor ZT‐1a treatment regimen (days 14–35 post‐surgery). Mice were then evaluated for cognitive functions by Morris water maze, WML by ex vivo MRI‐DTI analysis, and astrogliosis/demyelination by immunofluorescence and immunoblotting. Results Compared to sham control mice, BCAS‐Veh mice exhibited chronic cerebral hypoperfusion and memory impairments, accompanied by significant MRI DTI‐detected WML and oligodendrocyte (OL) death. Increased activation of WNK‐SPAK‐NKCC1‐signaling proteins was detected in white matter tissues and in C3d+GFAP+ cytotoxic astrocytes but not in S100A10+GFAP+ homeostatic astrocytes in BCAS‐Veh mice. In contrast, ZT‐1a‐treated BCAS mice displayed reduced expression and phosphorylation of NKCC1, decreased astrogliosis, OL death, and WML, along with improved memory functions. Conclusion BCAS‐induced upregulation of WNK‐SPAK‐NKCC1 signaling contributes to white matter‐reactive astrogliosis, OL death, and memory impairment. Pharmacological inhibition of the SPAK activity has therapeutic potential for alleviating pathogenesis and memory impairment in VCID.

Modulation of brain cation-Cl- cotransport via the SPAK kinase inhibitor ZT-1a

Abstract TP17: SPAK Kinase Inhibitor ZT-1a Prevents Reactive Astrogliosis, Blood-Brain Barrier Breakdown, and Demyelination in a Mouse Model of VCID

Functional Kinomics Establishes A Critical Node Of Volume-Sensitive Cation-Cl- Cotransporter Regulation In The Mammalian Brain

Role of SPAK–NKCC1 signaling cascade in the choroid plexus blood–CSF barrier damage after stroke

SPAK inhibitor ZT‐1a attenuates reactive astrogliosis and oligodendrocyte degeneration in a mouse model of vascular dementia

Modulation of Cerebrospinal Fluid Dysregulation via a SPAK and OSR1 Targeted Framework Nucleic Acid in Hydrocephalus

Efficacy of Novel SPAK Inhibitor ZT-1a Derivatives (1c, 1d, 1g & 1h) on Improving Post-Stroke Neurological Outcome and Brain Lesion in Mice

Inhibition of Na+-K+-2Cl− Cotransporter Attenuates Blood-Brain-barrier Disruption in a Mouse Model of Traumatic Brain Injury

Role of Elevated Thrombospondin-1 in Kainic Acid-Induced Status Epilepticus.

A modulator of the low-voltage activated T-type calcium channel that reverses HIV glycoprotein 120-, paclitaxel-, and spinal nerve ligation-induced peripheral neuropathies.

Molecular basis for regulation of human potassium chloride cotransporters

Targeting Modulation of the Choroid Plexus Blood-Csf Barrier and CSF Hypersecretion Via Lipid Nanoparticle-Mediated Co-Delivery Sirna and Resveratrol

Development of KCC2 therapeutics to treat neurological disorders

SLC26A11 Inhibition Reduces Oncotic Neuronal Death and Attenuates Stroke Reperfusion Injury

Phospho‐regulation, nucleotide binding and ion access control in potassium‐chloride cotransporters

A thallium transport FLIPR-based assay for the identification of KCC2-positive modulators

WNK-SPAK-NKCC1 Cascade Activation Contributes to Worsened Brain Damage in Mice With Hypertension Co-Morbidity after Ischemic Stroke

Structural bases for Na+-Cl- cotransporter inhibition by thiazide diuretic drugs and activation by kinases

Crossing the Chloride Channel: The Current and Potential Therapeutic Value of the Neuronal K+-Cl- Cotransporter KCC2

Down-regulation of the potassium-chloride cotransporter KCC2 contributes to spasticity after spinal cord injury

NKCC1 Inhibition Attenuates Chronic Cerebral Hypoperfusion-Induced White Matter Lesions by Enhancing Progenitor Cells of Oligodendrocyte Proliferation